Johnson and Johnson ( Johnson and Johnson )

Johnson and Johnson

Johnson and Johnson's picture

Caring for the world, one person at a time... inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Employees of the Johnson & Johnson Family of Companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.

Johnson and Johnson press release, blog etc

04/16/2018 - 18:06 Janssen Announces Worldwide Development and Commercialization Collaboration with Bristol-Myers Squibb to Advance a Next-Generation Therapy for Cardiovascular Diseases
04/16/2018 - 11:06 Newly Published Phase 2 Study Found Esketamine Demonstrated Significantly Rapid Improvements in Depressive Symptoms and Suicidality
04/12/2018 - 04:51 INVOKANA (canagliflozin) Demonstrated Significant Renal Protective Benefits in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease
04/11/2018 - 10:40 Johnson & Johnson Vision Announces Revolutionary Contact Lens Innovation with ACUVUE OASYS with Transitions Light Intelligent Technology
04/05/2018 - 16:33 Johnson & Johnson Institute Adds Innovative Analytics-Based Learning Platform to Help Surgeons Improve Technical Skills and Clinical Outcomes Across a Range of Specialties
03/26/2018 - 14:15 Ethicon Highlights New Capabilities to Reduce Exposure to Surgical Smoke at the Association of PeriOperative Nurses (AORN) Conference
03/20/2018 - 14:52 Dominic J. Caruso to Retire as Chief Financial Officer of Johnson & Johnson
03/16/2018 - 08:05 Johnson & Johnson Announces Binding Offer from Platinum Equity to Acquire LifeScan, Inc.
03/15/2018 - 10:33 Janssen Announces U.S. FDA Breakthrough Therapy Designation for Erdafitinib in the Treatment of Metastatic Urothelial Cancer
03/11/2018 - 15:59 Late-breaking exploratory analysis from the CANVAS Program presented at the American College of Cardiologys 67
03/10/2018 - 11:11 New Late-Breaking Study Finds Wearable Electrocardiogram (ECG) Monitoring Patch Can Detect Atrial Fibrillation Earlier and More Efficiently than Routine Care
02/28/2018 - 08:37 Johnson & Johnson Human Performance Institute Invests in the Future of Wellbeing with New $18 Million Facility in Lake Nona Medical City
02/21/2018 - 06:53 Results Underscore the Urgent Need for Innovation to Help the Approximately Five Million People Living with Treatment-Resistant Depression
02/20/2018 - 08:34 Johnson & Johnson Medical Devices Companies Acquire Orthotaxy to Develop Next-Generation Robotic-Assisted Surgery Platform in Orthopaedics
02/16/2018 - 15:47 NEW TREMFYA (GUSELKUMAB) DATA DEMONSTRATES LONG-TERM SKIN CLEARANCE IN PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS
02/16/2018 - 10:36 JOHNSON & JOHNSON CONSUMER PRESENTS NEW SCIENTIFIC RESEARCH AT 2018 AMERICAN ACADEMY OF DERMATOLOGY ANNUAL MEETING
02/14/2018 - 14:17 ERLEADA (apalutamide), a Next-Generation Androgen Receptor Inhibitor, Granted U.S. FDA Approval for the Treatment of Patients with Non-Metastatic Castration-Resistant Prostate Cancer
02/08/2018 - 19:56 ERLEADA (apalutamide), a Next-Generation Androgen Receptor Inhibitor, Lowered Risk of Metastasis or Death in Patients with Non-Metastatic Castration-Resistant Prostate Cancer